Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
Simcere Pharma has formed a third drug...
Simcere Pharma of Nanjing agreed to sell...
Simcere Pharma will raise 400 million...
The Board of Simcere Pharma has...
Simcere Pharma’s Board of...
Simcere Pharma will go private, the last...
Merck is pulling out of its highly visible China drug JV...
Simcere Pharmaceutical of Nanjing struck...
Simcere Pharma of Nanjing acquired China...
Simcere Diagnostics (Simceredx)...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China